It is named a qualified therapy because it specially targets the CD38 which can be over expressed within the multiple myeloma cells. Darzalex is from a class of medicines identified as CD38 monoclonal antibodies. Darzalex is not a chemotherapy. DARZALEX® is offered being an intravenous (IV) infusion after dilution at https://silasv779osp2.wikifiltraciones.com/user